This announcement is a separate document:
天康生物：中信建投证券股份有限公司关于天康生物股份有限公司非公开发行股票募投项目结项并将节余募集资金永久补充流动资金的核查意见
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on the conclusion of Tiankang Biotech\'s non-public stock fundraising project and permanently replenishing working capital from savings raised
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated